MyCelx Technologies Corp.

MyCelx Technologies Corp.

LLSE:MYX
48.50
GBX
0.00
(0.00%)
889.28MMarket Cap
May 20Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
1.63
1
0.73
0.42
0.73
1.43
0.62
0.37
0.44
0.45
0.47
0.21
0.48
- -
Basic EPS, GAAP
0.04
-0.44
-0.2
-0.17
-0.06
0.16
-0.15
-0.31
-0.07
-0.18
-0.16
-0.12
0.01
- -
Free Cash Flow per Basic Share
-0.84
-0.33
-0.16
- -
0.01
-0.01
-0.14
-0.09
-0.2
-0.16
-0.06
-0.09
-0.04
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
1.44
1.35
1.17
1
0.95
1.12
1.06
0.71
0.65
0.47
0.31
0.22
0.23
0.22
Tangible Book Value per Share
1.39
1.31
1.13
0.96
0.9
1.07
1.01
0.67
0.61
0.44
0.28
0.19
0.21
0.19
Basic Weighted Avg Shares
13
14
19
19
19
19
19
19
19
22
23
23
24
23
Sales/Revenue/Turnover
21
14
14
8
14
27
12
7
8
10
11
5
12
- -
Operating Margin (%)
6.97
-39.29
-22.25
-37.66
-5.29
16.17
-20.2
-85.21
-48.27
-35.66
-30.55
-92.86
1.64
- -
Depreciation Expense
1
1
1
1
1
1
1
1
1
1
1
- -
1
- -
Net Income, GAAP
1
-6
-4
-3
-1
3
-3
-6
-1
-4
-4
-3
- -
- -
Effective Tax Rate (%)
57
- -
- -
- -
- -
28.1
- -
- -
- -
- -
- -
- -
0.89
- -
Profit Margin (%)
2.64
-43.59
-26.85
-41.39
-8.42
11.39
-24.85
-85.78
-16.81
-39.81
-33.98
-55.54
2.84
- -
Working Capital
10
14
11
9
10
13
12
8
8
7
4
3
4
3
LT Debt
2
2
2
2
2
2
2
2
1
1
1
1
- -
1
Total Equity
19
25
22
19
18
21
20
14
13
11
7
5
6
5
Return on Invested Capital (%)
3.16
- -
- -
- -
- -
14.85
- -
- -
- -
- -
- -
- -
2.86
- -
Return on Capital (%)
2.97
- -
- -
- -
- -
14.72
- -
- -
- -
- -
- -
- -
5.19
- -
Return on Common Equity (%)
3.18
-26.87
-15.52
-16.06
-6.32
15.83
-14.5
-36.23
-10.79
-34.03
-41.2
-43.85
6.12
- -

Capital Structure

USD

•

in mil. unless spec.
Dec'23
Jun'24
Dec'24
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
1
1
1
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
23
23
24
Market Capitalization
18
18
11

Working Capital

USD

•

in mil. unless spec.
Dec'23
Jun'24
Dec'24
Total Current Assets
6
6
7
Cash, Cash Equivalents & STI
- -
2
1
Accounts Receivable, Net
2
- -
1
Inventories
3
3
4
Total Current Liabilities
3
2
4
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-11.35%
-15.11%
7.52%
Free Cash Flow
60.44%
13.82%
-59.11%
Net Income, GAAP
-57.28%
-8.5%
-112.27%
Sales/Revenue/Turnover
16.25%
26.17%
139.49%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

USD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
11
2024
- -
- -
5
2025
- -
- -
12

Semi-annual Earnings Per Share

USD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
-0.16
2024
- -
- -
-0.12
2025
- -
- -
0.01

Semi-annual Dividends Per Share

USD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
- -
2024
- -
- -
- -
2025
- -
- -
- -

Company Description

CEO
Connie Mixon
Full Time Employees
18
Sector
Producer manufacturing
Industry
Industrial machinery
Address
1650 International Court Norcross GA United States 30093
IPO Date
Aug 4, 2011
Website
mycelx.com
Business
MYCELX Technologies Corporation (MYX.L) develops and provides advanced clean water and clean air filtration systems that permanently remove hydrocarbons, oils, organics, PFAS contaminants, and suspended solids from produced water, process wastewater, groundwater, and air streams using its proprietary polymer-coated media and patented technologies including REGEN media; the company offers oil removal solutions for upstream produced water, hydrocarbons removal from downstream process wastewater, PFAS treatment systems, marine water filtration products, stormwater products, PCB filters, mobile rental units, and related engineering, consultation, on-site services, and system integration primarily to the oil and gas, petrochemical, power, marine, heavy manufacturing, and environmental remediation sectors. Founded as a Georgia corporation and headquartered in Norcross, Georgia, USA, with engineering operations in Katy, Texas, a London office, and facilities in Al-Jubail, Saudi Arabia, MYCELX serves customers across six continents with over 70 US patents supporting its zero-downtime, chemical-free filtration that exceeds industry standards for purity and compliance. Recent developments include a July 2024 partnership enabling work on US Department of Defense PFAS remediation projects, a May 2025 short-term rental contract award for a mobile PFAS treatment system at a DoD site in North Dakota with potential extensions and in-house treatability analysis, an anticipated involvement in two PFAS trials convertible to commercial sales, a new Chairman of the Board appointment in September 2025, a January 2025 change of adviser, a November 2025 project award, final results for the year ended December 2024 released in May 2025 reporting ongoing losses amid path-to-profitability efforts, and alignment with US EPA actions on PFAS contamination announced in May 2025.